NCT06575738View on ClinicalTrials.gov

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 11, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

October 31, 2027

Conditions
ObesityAdolescent ObesityBody-Weight TrajectoryWeight Loss TrajectoryBariatric SurgeryAnti-obesity Agents
Interventions
DRUG

Injectable semaglutide

Subcutaneous weekly injectable semaglutide

BEHAVIORAL

Standard postoperative care

Standard postoperative care consists of behaviorally-focused interventions delivered by the interdisciplinary Bariatric Surgery Center team targeting nutrition, physical activity, sleep, and mental health at standard postoperative intervals.

Trial Locations (1)

80045

RECRUITING

Childrens Hospital Colorado, Aurora

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Colorado, Denver

OTHER